Updates from The Motley Fool

Latest updates on Corcept Therapeutics, Inc. from Fool.com.


Stock Performance

CORT vs. S&P 500 | 2 Year Performance
CORT 1-Day Stock Chart
CORT 5-Day Stock Chart
CORT 1-Month Stock Chart
CORT 3-Month Stock Chart
CORT 6-Month Stock Chart
CORT 1-Year Stock Chart
CORT 2-Year Stock Chart
CORT 5-Year Stock Chart
View Interactive CORT Charts
Sponsored by

Key Data Points

Primary metrics and data points about Corcept Therapeutics, Inc..
Current Price: $4.77
Prev Close: $5.07
Open: $5.08
Bid: $4.50
Ask: $6.87
Day's Range: $4.70 - $5.08
52wk Range: $3.22 - $7.67
Volume: 199,859
Avg Vol 202,783
Market Cap: $518.86M
P/E (ttm): -84.50
EPS (ttm): -$0.06
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Corcept Therapeutics, Inc..
CAPS Rating 2 out of 5
 
77 Outperform
27 Underperform
CAPS All Stars
 
13 Outperform
9 Underperform

How do you think Corcept Therapeutics, Inc. will perform against the market?



You pick for Corcept Therapeutics, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph K. Belanoff, CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Corcept Therapeutics, Inc..

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers